Entrar/Registro  
INICIO ENGLISH
 
Revista Mexicana de Anestesiología
   
MENÚ

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor

Directorio






>Revistas >Revista Mexicana de Anestesiología >Año 2014, No. S1


Martínez-Segura RT
¿Cómo hacer anestesia total intravenosa en obstetricia?
Rev Mex Anest 2014; 37 (S1)

Idioma: Español
Referencias bibliográficas: 66
Paginas: 275-283
Archivo PDF: 200.39 Kb.


Texto completo




FRAGMENTO

Después del descubrimiento del cloroformo, en 1831, y la demostración de sus efectos anestésicos en humanos, John Snow lo administró a la reina Victoria para el nacimiento del príncipe Leopoldo en 1853, lo que hizo muy popular el método en obstetricia.


Palabras clave: Sin palabras Clave


REFERENCIAS

  1. Royce HC. Choise of methods for conduction anesthesia in obstetrics. Anesthesia and Analgesia. 1950.

  2. Cheeley L. Nitrous oxide, trichlorethylene, and ether: A balanced anesthesia in obstetrics anesthesia and analgesia. 1955.

  3. Warltier DC. Pharmacogenetics of anesthetic and analgesic agents. Anesthesiology. 2005;102:663-671.

  4. Hawkins J, Arens J, Bucklin B, et al. Practice guidelines for obstetric anesthesia. Anesthesiology. 2007;106:843-63.

  5. Rathmell J, et al. Management of nonobstetric pain during pregnancy and lactation. Anesth Analg. 1997;85:1074-87.

  6. Niebyl J. Nonanesthetic drug during pregnancy and lactation. In: Chestnut DH (ed.). Obstetric Anesthesia. Principles and Practice. St Louis Mo: Mosby-Year Book Inc; 1994: 229-243.

  7. Martinez Segura RT, Delgado Cortés R. Farmacología Perinatal. En: Canto AL, Higgins LF. Anestesia Obstétrica. 2a edición. Manual Moderno; 2008: p. 21-44.

  8. Douglas JM. Fisiología y farmacología perinatales. En: Norris MC Anestesia Obstétrica. 2a Ed. México: McGraw Hill Interamericana; 1999: 121-142.

  9. Haberer JP, Diemunsch P. Anesthésie obstétricale. París, Francia: Encycl Med Chir. Elsavier Anestesia Réanimation; 2000: 536-595.

  10. Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinetic. 2004;43:487-514.

  11. Yentis S, May A, Malhotra S. Analgesia, anaesthesia and pregnancy. 2da ed. UK: Ed. Cambridge University Press; 2007.

  12. Althaus J, Wax J. Analgesia and anesthesia in labor. Obstet Gynecol Clin N Am. 2005:32;231-244.

  13. Zacny JP. Assesing that behavioral effects and abuse potential of propofol bolus injections in healthy volunteers. Drug Alcohol Dep. 1991;32:45-57.

  14. Martínez SRT, Alonso ZFA. Técnicas anestésicas en cirugía ambulatoria. Clínicas Mexicanas de Anestesiología. 2006;2:49-80.

  15. Manullang TR, Chun KEgan TD. The Use of remifentanil in general anesthesia for cesarean section in a parturient with recurrent aortic coarctation. Can J Anaesth. 2000;47:454-459.

  16. Chauvin M. Factores de variación farmacocinética. EMCAR. 2003;36:1- 10.

  17. Anderson G. Pregnancy-induced changes in pharmacokinetics. Clin Pharmacokinetic. 2005;44:989-1008.

  18. Dermitzaki E, Staikou C, Petropoulos G, et al. A randomized study of maternal serum cytokine levels following cesarean section under general or neuraxial anesthesia. International Journal of Obstetric Anesthesia. 2009;18:33-37.

  19. Baden J, Rice S. Metabolism and toxicity of inhaled anesthetics. In: Miller R (ed.). Anesthesia. 5th edition. Philadelphia: Churchill Livingstone; 2000: 147-173.

  20. Bhavani-Shankar K, Chandrasekhar S, et al. Airway changes during labor and delivery. Anesthesiology. 2008;108:357-362

  21. Allegaert K, Velde van M, Anker van den J. Neonatal clinical pharmacology. Pediatric Anesthesia. 2014;24:30-38.

  22. King H, Ashley S, Brathwaute D, et al. Adequacy of general anesthesia for cesarean section. Anesth Analg. 1993;77:84-88.

  23. Robins K, Lyons G. Intraoperative awareness during general anesthesia for cesarean delivery. Obstetric Anesthesiology. 2009; 109:886-890.

  24. Milon D, Benhamou D. For safe drug administration and monitoring of the mother and neonate, we must know how pregnancy alters physiology, and the factors that affect placental transfer. Clin Pharmacokinetic. 1995;28:235-269.

  25. Craft JB, et al. Placental passage and uterine effects of fentanyl. Anesth Analg. 1983;62:894-898.

  26. Rayburn W et al. Fentanyl citrate analgesia during labor. Am J Obstet Gynecol. 1989;161:202.

  27. Campbell DC. Parenteral opioids for labor analgesia. Clinical Obstetrics and Gynecology. 2003;46:616-622.

  28. Rosaeg OP, et al. Maternal and fetal effects of intravenouos patientcontrolled fentanyl analgesia during labour in a trombocytopenic parturient. Can J Anaesth. 1992;39:277.

  29. Rout CC, Rocke DA. Effects of alfentanil and fentanyl on induction of anesthesia in patients with severe pregnancy induced hypertension. Br J Anaesth. 1990;65:468.

  30. Preston PG, Rosen MA, Hugs SC. Epidural anesthesia with fentanyl and lidocaine for cesarean section: maternal effects and neonatal outcome. Anesthesiology. 1988;68:938.

  31. Loftus JR, Hill H, Cohen SE. Placental transfer and neonatal effects of epidural sufentanil and fentanyl administered with bupivacaine during labor. Anesthesiology. 1995;83:300.

  32. Capogna G, Camorcia M, et al. Minimum analgesic dose of fentanyl and sufentanil for epidural analgesia in the fi rst stage of labor. Anesth Analg. 2003;96:1178-1182.

  33. Gambús PLC, Shafer SL. Aspectos farmacocinéticos de la anestesia intravenosa. En: Gambús PLC, Shafer SL (eds.). Dosifi cación racional de los anestésicos. México: Edikamed; 1999: pp. 29-52.

  34. Chauvin M. Remifentanil. Farmacología de los morfi nicos y antagonistas de la morfi na. Francia: Enciclopedia Médico Quirúrgica; 2001;36:371- A-10

  35. Kan R, Hughes S, Rosen M, et al. Intravenous remifentanil. Placental transfer, maternal and neonatal effects. Anesthesiology. 1998;88:1467- 1474.

  36. Santos Iglesias LJ, Sánchez JL, et al. Anestesia general con remifentanilo en dos casos de cesárea urgente. Rev Esp Anestesiol Reanim. 2001;48:244-247.

  37. Owen MD, Poss MJ, Dean LS, Harper MA. Prolonged intravenous remifentanil infusion for labor analgesia. Anesth Analg. 2002;94:918-919.

  38. Saunders AT, Glass SAP. A trial of labor for remifentanil. Anesth Analg. 2002;94:771-773.

  39. Volikas I, Butwick A, Wilkinson C. Maternal and neonatal side-effects of remifentanil patient. Controlled analgesia in labour. Br J Anaestha. 2005;95:504-509.

  40. Mattingly JE, D’Alessio J, Ramanathan J. Effects of obstetric analgesics and anesthetics on the neonate: a review. Paediatr Drugs. 2003;5:615- 627.

  41. D’Onofrio P, Melani AM, Mecacci F, Scarselli G. The effi cacy and safety of continuous intravenous administration of remifentanil for birth pain relief: An open study of 205 parturients. Anesth Analg. 2009;109:1922- 19224.

  42. Ngan KWD, Khaw SK, Ma CK, Wong YAS, Lee BB. Maternal and neonatal effects of remifentanil at induction of general anesthesia for cesarean delivery. A Randomized, double-blind, controlled trial. Anesthesiology. 2006:104;14-20.

  43. Welzing L, Ebenfeld S, Dlugay V, Wiesen HJM, Roth B, Mueller C. Remifentanil degradation in umbilical cord blood of preterm infants. Anesthesiology. 2011;114:570-577.

  44. Hill D. The use of remifentanil in obstetrics. Anesthesiology Clin. 2008;26:169-182.

  45. Tsen LC. Anesthetic management of the parturient with cardiac and diabetic diseases. Clinical Obstetrics and gynecology. 2003;46:700- 710.

  46. Bedard JM, Richardson MG, Wissler RN. General anesthesia with remifentanil for cesarean section in parturient with an acoustic neuroma. Can J Anesth. 1999;46:576-580.

  47. Scott H, Bateman C, Price M. The use of remifentanil in general anesthesia for cesarean section in a patient with mitral valve disease. Anaesthesia. 1998;53:695-697.

  48. McKechnie FB, Converse JG. Placental transmission of thiopental. Am J Obstet Gynecol. 1955;70:639.

  49. Kosaka Y, Takahashi T, Mark LC. Intravenous thiobarbiturate anesthesia for cesarean section. Anesthesiology. 1981;31:489.

  50. Bland B, Lawes E, Duncan P. Comparision of midazolam and thiopental for rapid sequence anesthetic induction for elective cesarean section. Anesth Analg. 1987;66:1165-1168.

  51. Laegreid L, Olegard R. Teratogenic effects of benzodiazepine use during pregnancy. J Pediatr. 1989;114:126-131.

  52. Ellingson A, Haram K, Sagen N, et al. Transplacental passage of ketamine after intravenous administration. Acta Anaesth Scand. 1977;21:41-44.

  53. Subramaniam K, Subramaniam B, Steinbrook R. Ketamine as adjuvant analgesic to opioids: A quantitative and qualitative systematic review. Anesth Analg. 2004;99:482-95.

  54. American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Practice guidelines for obstetric anesthesia. An Updated Report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Anesthesiology. 2007;106:843-863.

  55. Gregory MA, Davidson DG. Plasma etomidate levels in mother and fetus. Anaesthesia. 1991;46:716-718.

  56. Wagner RL, White PF. Etomidate inhibits adrenocortical function in surgical patients. Anesthesiology. 1984;61:647-651.

  57. Moore J. A comparison between propofol and thipoentone as induction agents in obstetric Anaeshtesia. Anaesthesia. 1989;44:753-757.

  58. Gin T, Gregory MA, Chan K, Oh TE. Efectos hemodinámicos de propofol y tiopental para inducción anestésica en cesárea. Anaesth Intensive Care. 1990;18:175.

  59. Lacassie H. TIVA en Obstetricia. En: Sepulveda P (ed.) La anestesia intravenosa. Bases teóricas y experiencia clínica. Chile: Editorial Universidad del Desarrollo; 2004: 119-122.

  60. Avram MJ, Henhorn TK. What’s new in pharmacokinetics and pharmacodynamics? Anesth Clin North Am. 1988;6:257-280.

  61. Gin T. Pharmacokinetics of propofol in women undergoing elective cesarean section. Br J Anesth. 1990;64:148-153.

  62. Dailland P, Cockshott I, Didier L, et al. Intravenous propofol during cesarean section: placental transfer, concentration in breast milk, and neonatal effects. Anesthesiology. 1989;71:827.

  63. Kenichi Masui MD, et al. Early phase pharmacokinetics but not phatmacodynamics are infl uenced by propofol infusion rate. Anesthesiology. 2009;111:805-817.

  64. Watsnon KR, Shah MV. Clinical comparison of “single agent” anaestehesia with sevofl urane versus target controlled infusion of propofol. British Journal of Anesthesia. 2006;85(4):541-546.

  65. Russel D, et al. Manual compared with target-controlled infusion of propofol. British Journal of Anaesthesia. 1995;75:562-566.

  66. Absalom AR, Kenny GNC. Closed-loop control of propofol anaesthesia using bispectral index: performance assessment in patients receiving computer-controlled propofol and manually controlled remifentanil infusions for minor surgery. Br J Anaesth. 2003;90:737- 741.



>Revistas >Revista Mexicana de Anestesiología >Año2014, No. S1
 

· Indice de Publicaciones 
· ligas de Interes 






       
Derechos Resevados 2019